Acta Neuropharmacologica››2013,Vol. 3››Issue (4): 14-22.
Previous ArticlesNext Articles
LIU Hong-bin，WU Hai-xia
Online:2013-08-26Published:2014-06-27CLC Number:
LIU Hong-bin，WU Hai-xia.Overview of the Pathogenesis and Animal Models of Alzheimer's Disease[J]. Acta Neuropharmacologica, 2013, 3(4): 14-22.
| [1] Alzheimer's Association. Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2012, 8(2): 131-168. [2] Goedert M, Spillantini M G. A century of Alzheimer's disease[J] Science, 2006, 314(5800): 777-781. [3] Zhao Guo-jun, Cui Mei-zhen, Mao Guo-zhang, et al. Gamma cleavage is dependent on zeta cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain[J]. J Biol Chem, 2005, 280(45):37689-37697. [4] Thorlakur Jonsson, Jasvinder K Atwal, Stacy Steinberg, et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline[J]. Nature, 2012, 488(7409):96-99. [5] Kuo Yu-Min, Mark R Emmerling, Carmen Vigo-Pelfrey, et al. Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains[J]. J Bio Chem, 1996, 271(8):4077-4081. [6] Dimitra G Georganopoulou, Chang Lei, Jwa-Min Nam, et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease[J]. Proc Natl Acad Sci USA, 2005, 102 (7): 2273-2276. [7] Igor Klyubin, Domminic M Walsh, Cynthia A Lemere, et al. Amyloid beta Protein immunotherapy neutralizes Abeta Oligomers that disrupt synaptic plasticity in vivo[J]. Nat Med, 2005, 11(5): 556-561. [8] Bart Dermaut, Samir Kumar-Singh, Rosa Rademakers, et al. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum[J]. Trends Genet, 2005, 21(12): 664-672. [9] Carlo Ballatore, Virginia M-Y Lee, John Q Trojanowski. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders[J]. Nat Rev Neurosci, 2007, 8(9): 663-672. [10] Town T, Nikolic V, Tan J. The microglial activation continuum from innate to adaptive responses [J]. Neuro Inflamation, 2005, 2 (24):1472-1483. [11] Sofroniev M V, Peaison R C. Degeneration of cholineigic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in die rat [J]. Brain Res, 1985, 339(1):186-190. [12] Nabeshima T. Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle [J]. Nihon Shinkei Seishin Yakurigaku Zasshi, 1995, 15(5): 411-418. [13] Alvarez X A, Miguel-Hidalgo J J, Fernandez-Novoa L, et al. Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats [J]. Methods Find Exp Clin Phamacol, 1997, 19(7):471-479. [14] Tian Q, Lin Z Q, Wang X C, et al．Injection of okadaic acid into the Meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit [J]. Neuroscience, 2004, 126(2): 277-284. [15] Yin Yang-Yang, Liu Hao, Cong Xiao-Bin, et al．Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats [J]. J Alzheimer's Dis, 2010, 19(2):735-746. [16] Joanna L Jankowsky, Linda H Younkin, Victoria Gonzales, et al. Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice[J]. J Biol Chem, 2007, 282(31):22707-22720. [17]Games D, Buttini M, Kobayashi D, et al. Mice as models: transgenic approaches and Alzheimer's disease [J]. J Alzheimers Dis, 2006, 9(3Suppl): 133-149. [18] Charles Duyckaerts, Marie Claude Potier, Benoit Delatour. Alzheimer disease models and human neuropathology: similarities and differences [J]. Acta Neuropathol, 2008, 115(1):5-38. [19] Martin C Herzig, David T Winkler, Patrick Burgermeister, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis [J]. Nat Neurosci, 2004, 7(9):954-960. [20] Miao Jian-ting, Xu Feng, Davis Judianne, et al. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein [J]. Am J Pathol, 2005, 167(2):505-515. [21] Jada Lewis, Eileen McGowan, Julia Rockwood, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein[J]. Nat Genet, 2000, 25(4):402-405. [22] Jurgen Gotz, Andreas Schild, Fred Hoemd1i, et al. Amyloid-induced neurofibrillary tangle formation in Alzheimer’s disease insight from transgenic mouse and tissue-culture models[J]. Int J Dev Neurosci, 2004, 22(7):453-465. [23] Borchelt D R. Metabolism of presenilin 1: influence of presenilin 1 on amyloid precursor protein processing [J]. Neurobiol Aging, 1998, 19(1):15-18. [24] Holly Oakley, Sarah L Cole, Sreemathi Logan, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation[J].J Neurosci, 2006, 26(40):10129-10140. [25] Jada Lewis, Dennis W Dickson, Lin Wen-Lang, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP [J]. Science, 2001, 293(5534):1487-1491. [26] Salvatore Oddo, Antonella Caccamo, Masashi Kitazawa, et al. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease [J]. Neurobiol Aging, 2003, 24(8):1063-1070. [27] Aida Attar, Liu Ting-yu, Chan Wai-ting, et al. A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease [J]. J Pharm Pharmacol, 2013, 65(12):1753-1756. [28] Sarantseva S V, Bolshakova O I, Timoshenko S I, et al. Studying pathogenesis of Alzheimer’s disease in a drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin [J]. Genetika, 2009, 45(1): 119-126. [29] Mark E Fortini, Nancy M Bonini. Modeling human neurodegenerative disease in drosophila[J]. Trends Genet, 2000, 16(4): 161-167. [30] Tomonori Kurokawa, Shinji Asada, Shinobu Nishitani, et al. Age-related changes in manganese superoxide dismutase activity in the cerebral cortex of senescence-ccelerated prone and resistant mouse[J].Neurosci Lett, 2001, 298 (2):135-138. [31] Yang Wei-na, Han Hua, Hu Xiao-dan, et al. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress [J].Pharmacol Biochem Behav, 2013, 114:31-36. [32] Walsh T J, Herzog C D, Gandhi C, et al. Injection of IgG 192-saporin into the medial septum produces cholinergic hypofunction and dose-dependent working memory deficits [J].Brain Res, 1996, 726(1-2):69-79. [33] Hanna Rosenmann, Nikolaos Grigoriadis, Dimitrios Karussis, et al. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein [J]. Arch Neurol, 2006, 63(10):1459-14067. |
| [1] | ZHANG Li-huan, CHU Bao, ZHANG Xiao-yan, SUN Ying-ru, GONG Chun-dong, WANG He-bo.Research Progress of Magnesium in Pathogenesis and Treatment of Migraine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 29-33. |
| [2] | HE Pan, LIU Yue-tao, DU Guan-hua, QIN Xue-mei.Research Advances in Sarcopenia[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 47-53. |
| [3] | ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pulmonary Tuberculosis[J]. Acta Neuropharmacologica, 2019, 9(6): 11-14. |
| [4] | ZHANG Dan-shen1，MA Jia-cheng2.Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, 2019, 9(6): 15-20. |
| [5] | ZHANG Dan-shen，JIN Shan.Methods and Evaluation of Animal Models of Induced Silicosis[J]. Acta Neuropharmacologica, 2019, 9(6): 21-25. |
| [6] | ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pneumonia[J]. Acta Neuropharmacologica, 2019, 9(5): 17-23. |
| [7] | ZHANG Dan-shen，LI Jia-ying.Methods and Evaluation of Animal Models of Induced Pulmonary Hypertension[J]. Acta Neuropharmacologica, 2019, 9(5): 24-29. |
| [8] | ZHANG Dan-shen，LI Lan.Methods and Evaluation of Animal Models of Induced Emphysema[J]. Acta Neuropharmacologica, 2019, 9(5): 30-33. |
| [9] | ZHANG Dan-shen，WANG Fei-fan.Methods and Evaluation of Animal Models of Induced Pulmonary Edema[J]. Acta Neuropharmacologica, 2019, 9(5): 34-39. |
| [10] | ZHANG Dan-shen，ZHANG Nan.Methods and Evaluation of Animal Models of Induced Bronchial Asthma[J]. Acta Neuropharmacologica, 2019, 9(4): 1-8. |
| [11] | SUN Cheng-cheng，LIU Jian-gang，LIU Mei-xia，LI Hao，LUO Zeng-gang.Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models[J]. Acta Neuropharmacologica, 2019, 9(1): 13-17. |
| [12] | LI Wei，ZHANG Dan-shen.Methods and Evaluation of Animal Models of Induced Chronic Bronchitis[J]. Acta Neuropharmacologica, 2019, 9(1): 18-22. |
| [13] | LIANG Jian-hui1,2*, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4.Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice[J]. Acta Neuropharmacologica, 2018, 8(4): 44-45. |
| [14] | ZHANG Dan-shen，ZHANG Rui-juan.Methods and Evaluation of Animal Models of Induced Acute Respiratory Distress Syndrome[J]. Acta Neuropharmacologica, 2017, 7(6): 7-14. |
| [15] | LIANG Hui，CHENG Tao，LIANG Jian-hui.Progress in the Comorbidity of Depression and Anxiety[J]. Acta Neuropharmacologica, 2017, 7(6): 30-35. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
